EFX
30
3
DD
41
-3
TAP
35
4
NAVI
40
2
HPQ
37
6
YUM
58
2
EQR
25
5
PSA
35
15
LOW
24
-4
PBI
42
-4
AMT
39
3
FOX
26
-2
SWK
46
-3
V
40
4
PNC
59
3
GM
57
-6
RSG
54
4
STI
49
2
LRCX
56
-5
PNW
69
2
EFX
30
3
DD
41
-3
TAP
35
4
NAVI
40
2
HPQ
37
6
YUM
58
2
EQR
25
5
PSA
35
15
LOW
24
-4
PBI
42
-4
AMT
39
3
FOX
26
-2
SWK
46
-3
V
40
4
PNC
59
3
GM
57
-6
RSG
54
4
STI
49
2
LRCX
56
-5
PNW
69
2
Financhill
Back

Evofem Biosciences, Inc. 10K Form

Sell
40

EVFM
Evofem Biosciences, Inc.

Last Price:
$0.0100
Seasonality Move:
-9.07%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EVFM News And Ratings

See the #1 stock for the next 7 days that we like better than EVFM

EVFM Financial Statistics

Sales & Book Value

Annual Sales: $20.2M
Cash Flow: $28K
Price / Cash Flow: 0
Annual Sales: $-0.59
Price / Book: 0

Profitability

EPS (TTM): -0.00740
Net Income (TTM): $391K
Gross Margin: $15M
Return on Equity: 0%
Return on Assets: 2.3%

Evofem Biosciences, Inc. Earnings Forecast

Key Evofem Biosciences, Inc. Financial Ratios

  • The Gross Profit Margin over the past 14 years for EVFM is 74.56%.
  • The Selling, General & Administrative Expenses for EVFM have been equal to 84.60% of Gross Profit Margin.
  • The Research & Development expenses have been -17.17% of Revenue.
  • The Interest Expense is 673.91% of Operating Income.
  • The Net Earning history of EVFM is 1.94% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 8 years.

Evofem Biosciences, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: EVFM
CUSIP: 30048L
Website: evofem.com

Debt

Debt-to-Equity Ratio: -0.79
Current Ratio: 0.18
Quick Ratio: 0.15

Price-to-Earnings

Trailing P/E Ratio: 0.18
Forward P/E Ratio: 0

EVFM Technical Analysis vs Fundamental Analysis

Sell
40
Evofem Biosciences, Inc. (EVFM) is a Sell

Is Evofem Biosciences, Inc. a Buy or a Sell?